                         SEQUENCE LISTING

<110>  The United States of America, as represented by the 
       Secretary, Department of Health and Human Services
 
<120>  SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE

<130>  4239-105930-02

<150>  US 63/214,081
<151>  2021-06-23

<160>  46    

<170>  PatentIn version 3.5

<210>  1
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthethic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  1

Glu Lys Xaa Arg Asp Leu Tyr Ser Lys Xaa Thr Ala Ala Met Ser Thr 
1               5                   10                  15      


Tyr Thr Gly Ile Phe Thr Asp Gln Val Leu Ser Val Leu Lys Gly Glu 
            20                  25                  30          


Glu 
    


<210>  2
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  2

Glu Lys Leu Arg Asp Leu Tyr Ser Lys Ser Thr Ala Ala Xaa Ser Thr 
1               5                   10                  15      


Tyr Xaa Gly Ile Phe Thr Asp Gln Val Leu Ser Val Leu Lys Gly Glu 
            20                  25                  30          


Glu 
    


<210>  3
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  3

Glu Lys Leu Arg Asp Leu Tyr Ser Lys Ser Xaa Ala Ala Met Ser Thr 
1               5                   10                  15      


Tyr Xaa Gly Ile Phe Thr Asp Gln Val Leu Ser Val Leu Lys Gly Glu 
            20                  25                  30          


Glu 
    


<210>  4
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  4

Glu Lys Leu Arg Asp Leu Tyr Ser Lys Ser Thr Ala Ala Met Xaa Thr 
1               5                   10                  15      


Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val Leu Lys Gly Glu 
            20                  25                  30          


Glu 
    


<210>  5
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is S)-alpha-methyl,alpha-pentenylglycine

<400>  5

Ser Thr Ala Ala Met Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val 
1               5                   10                  15      


Leu Ser Val Leu Lys Gly Glu Glu 
            20                  


<210>  6
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  6

Glu Lys Xaa Arg Asp Leu Tyr Ser Lys Xaa Thr Ala Pro Ala Met Ser 
1               5                   10                  15      


Thr Tyr Thr Gly Ile Phe Thr Asp Gln Val Leu Ser Val Leu Lys Gly 
            20                  25                  30          


Glu Glu 
        


<210>  7
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  7

Ala Met Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Leu Lys Gly Glu Glu 
            20      


<210>  8
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  8

Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val Leu Lys 
1               5                   10                  15      


Gly Glu Glu 
            


<210>  9
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MOD_RES
<222>  (25)..(25)
<223>  AMIDATION

<400>  9

Ser Thr Ala Ala Met Xaa Thr Tyr Thr Gly Ile Phe Xaa Thr Asp Gln 
1               5                   10                  15      


Val Leu Ser Val Leu Lys Gly Glu Glu Ala Met Ile Asp 
            20                  25                  


<210>  10
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  D-Glu

<400>  10

Ser Thr Ala Ala Met Xaa Thr Tyr Thr Gly Ile Phe Xaa Thr Asp Gln 
1               5                   10                  15      


Val Leu Ser Val Leu Lys Gly Glu Glu 
            20                  25  


<210>  11
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  11

Ser Thr Ala Ala Xaa Ser Thr Tyr Thr Gly Ile Xaa Thr Asp Gln Val 
1               5                   10                  15      


Leu Ser Val Leu Lys Gly Glu Glu 
            20                  


<210>  12
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

Glu Lys Leu Arg Asp Leu Tyr Ser Lys Ser Thr Ala Pro Ala Met Ser 
1               5                   10                  15      


Thr Tyr Thr Gly Ile Phe Thr Asp Gln Val Leu Ser Val Leu Lys Gly 
            20                  25                  30          


Glu Glu 
        


<210>  13
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Glu Lys Leu Arg Asp Leu Tyr Ser Lys Ser Thr Ala Ala Met Ser Thr 
1               5                   10                  15      


Tyr Thr Gly Ile Phe Thr Asp Gln Val Leu Ser Val Leu Lys Gly Glu 
            20                  25                  30          


Glu 
    


<210>  14
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  14

Ala Met Ser Thr Tyr Thr Gly Ile Phe Thr Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Leu Lys Gly Glu Glu 
            20      


<210>  15
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  15

Asp Tyr Leu Lys Glu Val Phe Glu Lys Leu Arg Asp Leu Tyr Glu Lys 
1               5                   10                  15      


Phe Thr Pro Ala Val Ser Thr Tyr Thr Gly Ile Phe Thr Asp Gln Val 
            20                  25                  30          


Leu Ser Val Leu Lys Gly Glu Glu 
        35                  40  


<210>  16
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  X is (S)-alpha-methyl,alpha-octenylglycine

<400>  16

Ala Met Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Xaa Lys Gly Glu Glu 
            20      


<210>  17
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  17

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Ser Lys Gly Glu Glu 
            20      


<210>  18
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  X is (S)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  18

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Xaa Lys Xaa Glu Glu 
            20      


<210>  19
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  19

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Xaa Ser Val 
1               5                   10                  15      


Leu Lys Gly Glu Glu 
            20      


<210>  20
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  X is alpha-methyl-Lysine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  20

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Xaa Ser Val 
1               5                   10                  15      


Leu Xaa Gly Glu Glu 
            20      


<210>  21
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MOD_RES
<222>  (21)..(21)
<223>  PYRROLIDONE CARBOXYLIC ACID

<400>  21

Ala Met Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Leu Lys Gly Glu Xaa 
            20      


<210>  22
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is (R)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  X is (R)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  22

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Xaa Leu Ser Val 
1               5                   10                  15      


Xaa Lys Gly Glu Glu 
            20      


<210>  23
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  23

Glu Lys Leu Arg Asp Leu Tyr Ser Lys Ser Thr Ala Pro Ala Xaa Ser 
1               5                   10                  15      


Thr Tyr Xaa Gly Ile Phe Thr Asp Gln Val Leu Ser Val Leu Lys Gly 
            20                  25                  30          


Glu Glu 
        


<210>  24
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (32)..(23)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  misc_feature
<222>  (32)..(32)
<223>  Xaa can be any naturally occurring amino acid

<400>  24

Glu Lys Leu Arg Asp Leu Tyr Ser Lys Ser Thr Ala Ala Met Ser Thr 
1               5                   10                  15      


Tyr Thr Gly Ile Phe Thr Asp Gln Xaa Leu Ser Val Leu Lys Gly Xaa 
            20                  25                  30          


Glu 
    


<210>  25
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  25

Glu Lys Xaa Arg Asp Leu Tyr Ser Lys Xaa Thr Ala Ala Phe Ser Thr 
1               5                   10                  15      


Tyr Phe Gly Ile Phe Thr Asp Gln Val Leu Ser Val Leu Lys Gly Glu 
            20                  25                  30          


Glu 
    


<210>  26
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<400>  26

Glu Lys Xaa Arg Asp Leu Tyr Ser Lys Xaa Thr Ala Ala Phe Ser Thr 
1               5                   10                  15      


Tyr Thr Phe Ile Phe Thr Asp Gln Val Leu Ser Val Leu Lys Gly Glu 
            20                  25                  30          


Glu 
    


<210>  27
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is (R)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  27

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Xaa Ser Val 
1               5                   10                  15      


Leu Lys Gly Glu Glu 
            20      


<210>  28
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (S)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  28

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Xaa Ser Val 
1               5                   10                  15      


Leu Lys Gly Glu Glu 
            20      


<210>  29
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is (R)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  X is alpha-methyl-Lysine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  29

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Xaa Ser Val 
1               5                   10                  15      


Leu Xaa Gly Glu Glu 
            20      


<210>  30
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (S)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  X is alpha-methyl-Lysine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  30

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Xaa Ser Val 
1               5                   10                  15      


Leu Xaa Gly Glu Glu 
            20      


<210>  31
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is (S)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  D-Glu

<400>  31

Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val Xaa Lys 
1               5                   10                  15      


Ser Ser Glu Glu 
            20  


<210>  32
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  X is (S)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  32

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Xaa Lys Xaa Glu Glu 
            20      


<210>  33
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  X is (S)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  D-Lys

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  33

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Xaa Asp Gln Val Leu Ser 
1               5                   10                  15      


Val Xaa Lys Xaa Glu Glu 
            20          


<210>  34
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-terminal acylation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  34

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Leu Lys Xaa Glu Glu 
            20      


<210>  35
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  35

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Leu Lys Xaa Glu Glu 
            20      


<210>  36
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Ala

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  D-Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  D-Lys

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  36

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Leu Lys Xaa Glu Glu 
            20      


<210>  37
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  LIPID
<222>  (1)..(1)
<223>  N-terminal octanoic

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  37

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Xaa Asp Gln Val Leu Ser 
1               5                   10                  15      


Val Leu Lys Xaa Glu Glu 
            20          


<210>  38
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  LIPID
<222>  (1)..(1)
<223>  N-terminal octanoic acid

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-GLu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-GLu

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  D-GLu

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  D-GLu

<400>  38

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Leu Lys Xaa Glu Glu Glu Glu 
            20              


<210>  39
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  LIPID
<222>  (1)..(1)
<223>  N-terminal octanoic acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  39

Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val Leu Lys 
1               5                   10                  15      


Xaa Glu Glu Glu Glu 
            20      


<210>  40
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-terminal Acylation

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is (S)-alpha-methyl,alpha-pentenylglycine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (23)..(23)
<223>  D-Glu

<400>  40

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Leu Lys Xaa Glu Glu Glu Glu 
            20              


<210>  41
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  X is (S)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  41

Ala Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Xaa Lys Xaa Glu Glu 
            20      


<210>  42
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-terminal octanoic acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is bis-pentenylglycine (S)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  D-Glu

<400>  42

Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val Xaa Lys 
1               5                   10                  15      


Xaa Glu Glu 
            


<210>  43
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-terminal octanoic acid

<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Aib

<220>
<221>  MOD_RES
<222>  (2)..(2)
<223>  Nle

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is (R)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is bis-pentenylglycine

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  X is (S)-alpha-methyl,alpha-octenylglycine

<220>
<221>  MOD_RES
<222>  (19)..(19)
<223>  MeGly

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  D-Glu

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  D-Glu

<400>  43

Xaa Xaa Xaa Thr Tyr Thr Gly Ile Phe Xaa Asp Gln Val Leu Ser Val 
1               5                   10                  15      


Xaa Lys Xaa Glu Glu 
            20      


<210>  44
<211>  79
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Syntthetic peptide

<400>  44

Thr Gln Gln Pro Gln Gln Asp Glu Met Pro Ser Pro Thr Phe Leu Thr 
1               5                   10                  15      


Gln Val Lys Glu Ser Leu Ser Ser Tyr Trp Glu Ser Ala Lys Thr Ala 
            20                  25                  30          


Ala Gln Asn Leu Tyr Glu Lys Thr Tyr Leu Pro Ala Val Asp Glu Lys 
        35                  40                  45              


Leu Arg Asp Leu Tyr Ser Lys Ser Thr Ala Ala Met Ser Thr Tyr Thr 
    50                  55                  60                  


Gly Ile Phe Thr Asp Gln Val Leu Ser Val Leu Lys Gly Glu Glu 
65                  70                  75                  


<210>  45
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is penicillamine

<220>
<221>  MOD_RES
<222>  (9)..(9)
<223>  MeGly

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  N-methylglycine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  C-terminal 6-aminohexanoic acid

<400>  45

Arg Phe Xaa Thr Gly His Phe Gly Xaa Xaa Tyr Pro Cys 
1               5                   10              


<210>  46
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  C-terminal 6-aminohexanoic acid

<400>  46

Val Met His Cys Phe Trp Asp Glu Glu Phe Lys Cys Asp Tyr Gly 
1               5                   10                  15  


